Cargando…

HDV RNA Levels and Progression of Hepatitis Delta Infection: A 14 Year Follow Up Experience in Italy

Background: Identification of outcome predictors is one of the unmet needs in chronic HDV infection. Until recently, no reliable quantitative assays for HDV RNA were available. Aims: To evaluate the impact of baseline viremia on natural history of HDV infection in a cohort of patients whose serum sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mangia, Alessandra, Squillante, Maria Maddalena, Fraticelli, Filippo, Cavorsi, Maria Chiara, Paroni, Giulia, Zaffarano, Lucia, Piazzolla, Annarita Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217045/ https://www.ncbi.nlm.nih.gov/pubmed/37408247 http://dx.doi.org/10.3390/cells12101413

Ejemplares similares

Effectiveness of Booster Dose of Anti SARS-CoV-2 BNT162b2 in Cirrhosis: Longitudinal Evaluation of Humoral and Cellular Response
por: Giambra, Vincenzo, et al.
Publicado: (2022)

Hepatitis C virus micro-elimination: Where do we stand?
por: Mangia, Alessandra, et al.
Publicado: (2021)

Nonalcoholic Steatohepatitis: A 9-Year Follow Up Cohort Study
por: Mangia, Alessandra, et al.
Publicado: (2022)

Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020)

Durability of immune response to SARS-CoV-2 vaccination in patients with liver cirrhosis (LC) as compared to healthcare workers (HW)
por: Mangia, Alessandra, et al.
Publicado: (2022)

Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis?
por: Mangia, Alessandra, et al.
Publicado: (2020)

Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare Workers
por: Cocomazzi, Giovanna, et al.
Publicado: (2021)

Hepatitis Delta Virus: HDV-HBV Interactions
por: Sureau, Camille
Publicado: (2006)

Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient‐centered program from Italy
por: Mangia, Alessandra, et al.
Publicado: (2021)

Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin
por: Netter, Hans J., et al.
Publicado: (2021)

SVR12 Higher than 97% in GT3 Cirrhotic Patients with Evidence of Portal Hypertension Treated with SOF/VEL without Ribavirin: A Nation-Wide Cohort Study
por: Mangia, Alessandra, et al.
Publicado: (2019)

Performance of Hepatitis Delta Virus (HDV) RNA Testing for the Diagnosis of Active HDV Infection: Systematic Review and Meta-analysis
por: Chen, Sisi, et al.
Publicado: (2023)

Management of Delta Hepatitis 45 Years after the Discovery of HDV
por: Brillanti, Stefano
Publicado: (2022)

High Rates of Hidden HCV Infections among Hospitalized Patients Aged 55–85
por: Piazzolla, Annarita Valeria, et al.
Publicado: (2021)

Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta
por: Wranke, Anika, et al.
Publicado: (2014)

2198. Increased Global Incidence and Altered Demographic Profile of Hepatitis Delta Virus (HDV)
por: Weller, Melodie, et al.
Publicado: (2018)

Circulation of HDV Genotypes in Brazil: Identification of a Putative Novel HDV-8 Subgenotype
por: Mello, Francisco C. A., et al.
Publicado: (2023)

HDV-Like Viruses
por: Pérez-Vargas, Jimena, et al.
Publicado: (2021)

AAV-HDV: An Attractive Platform for the In Vivo Study of HDV Biology and the Mechanism of Disease Pathogenesis (†)
por: Maestro, Sheila, et al.
Publicado: (2021)

Combination of Novel Therapies for HDV
por: Elazar, Menashe, et al.
Publicado: (2022)

A Review of HDV Infection
por: Caviglia, Gian Paolo, et al.
Publicado: (2022)

Prevalence of Hepatitis Delta Virus (HDV) Infection in Chronic Hepatitis B Patients with Unusual Clinical Pictures
por: Ghamari, Shiva, et al.
Publicado: (2013)

High Serum Levels of HDV RNA Are Predictors of Cirrhosis and Liver Cancer in Patients with Chronic Hepatitis Delta
por: Romeo, Raffaella, et al.
Publicado: (2014)

Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV Genotype
por: Dziri, Samira, et al.
Publicado: (2021)

Hepatitis B (HBV), Hepatitis C (HCV) and Hepatitis Delta (HDV) Viruses in the Colombian Population—How Is the Epidemiological Situation?
por: Alvarado-Mora, Mónica Viviana, et al.
Publicado: (2011)

Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
por: Giersch, Katja, et al.
Publicado: (2017)

Molecular epidemiology and clinical characteristics of hepatitis delta virus (HDV) infected patients with elevated transaminases in Shanghai, China
por: Wu, Shanshan, et al.
Publicado: (2020)

HDV infection rates in northern Vietnam
por: Binh, Mai Thanh, et al.
Publicado: (2018)

HBV and HDV: New Treatments on the Horizon
por: Zuccaro, Valentina, et al.
Publicado: (2021)

HDV Pathogenesis: Unravelling Ariadne’s Thread
por: Tseligka, Eirini D., et al.
Publicado: (2021)

Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
por: Mateo, Roberto, et al.
Publicado: (2023)

The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?
por: Hayashi, Tomoyuki, et al.
Publicado: (2021)

Systemic Inflammatory Molecules Are Associated with Advanced Fibrosis in Patients from Brazil Infected with Hepatitis Delta Virus Genotype 3 (HDV-3)
por: Souza Campos, Mauricio, et al.
Publicado: (2023)

Inhibition of telomerase activity by HDV ribozyme in cancers
por: Lu, Yingying, et al.
Publicado: (2011)

Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014)

Constraint of Base Pairing on HDV Genome Evolution
por: Nagata, Saki, et al.
Publicado: (2021)

Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection
por: Couto, Ingrid, et al.
Publicado: (2017)

Effects of flanking regions on HDV cotranscriptional folding kinetics
por: Wang, Yanli, et al.
Publicado: (2018)

In Vivo Models of HDV Infection: Is Humanizing NTCP Enough?
por: Giersch, Katja, et al.
Publicado: (2021)

Anti-HDV seroprevalance among patients with previous HBV infection
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9u1s6511ul5k8i579lpbii7rrl